The first of four Clinical Year in Review sessions highlighted the latest papers published on acute respiratory distress syndrome, pulmonary vascular disease, chronic obstructive pulmonary disease, and interstitial lung disease. Stephanie Christenson, MD, MS, discussed new approaches to change the course of COPD recommended by the Lancet Commission and incorporated into the 2023 GOLD Report.

The leaders of four phase two and phase three trials will present the results of their research for the first time in a public forum on Monday at the International Conference. The Clinical Trials Symposium will highlight groundbreaking work on therapies for pulmonary hypertension, COPD, and asthma.

In this first half of a two-part series on sleep, Megan M. Lowery, MD, Jose Bernardo Contreras, MD, and Kara Lindi Dupuy-McCauley, MD, will discuss causes of sleep-disordered breathing and explore guidelines for management.